iPS cell（ライセンス）
L62 iPS cell
This product is covered by one or more claims of the issued patents and pending patent applications: U.S. Patent Nos. 8,048,999, 8,058,065, 8,129,187, 8,211,697, 8,257,941, 8,278,104, 8,530,238, 8,900,871, 8,927,277, 8,951,801, 9,213,999, 9,404,124, 9,499,797, 9,677,141 and 9,714,433, and foreign counterparts thereof, including their divisions, continuations, extensions, substitutions, and those claiming priority therefrom or those claiming the same priorities therein.
This custom service is provided by Takara Bio Inc. based on a patent license from iPS Academia Japan, Inc. The use of iPSCs produced by this service (hereinafter referred to as the "custom iPSCs") is strictly limited to customer's own internal research. Customer cannot have any right to use the custom iPSCs in humans for any purposes including but not limited to diagnostics and/or therapeutics, or otherwise clinical trials. There is no right to resell or transfer the custom iPSCs to a third party regardless of whether or not compensation is received.
The use of custom iPSCs is not allowed for the purposes of the intended use as described below: 1) Creation of a human clone through transplantation of the custom iPSCs-derived embryos into human or animal individuals, 2) Custom iPSCs transplantation into human embryos, 3) Custom iPSCs transplantation into human fetuses, and 4) Production of human embryos using the custom iPSCs-derived germ cells.
Customers wishing to use the custom iPSCs for purposes other than internal research use should contact us. No express or implied license is granted to the customer. Any use of the custom iPSCs for Commercial Purposes requires a patent license from iPS Academia Japan, Inc. "Commercial Purposes" means at least one of following activities including the use of custom iPSCs: 1) Use for manufacture of related products for sale including but not limited to culture medium or equipment, 2) Use in order to provide a service to a third party (including use of the differentiated cells from the custom iPSCs), 3) Use for screening compounds, antibodies, proteins, peptides and others in developing pharmaceuticals (including diagnostic agents) for human and/or animal use (including use of the differentiated cells from the custom iPSCs)*, and 4) Transfer to a third party (including transfer of the differentiated cells from the custom iPSCs).
*A patent license to use the custom iPSCs and the use of the differentiated cells from the custom iPSCs for screening compounds may also be granted from Takara Bio Inc.
L69 Differentiated cell from iPS cell
This product is covered by one or more claims of the issued patents and pending patent applications: U.S. Patent Nos. 8,048,999, 8,058,065, 8,129,187, 8,211,697, 8,257,941, 8,278,104, 8,530,238, 8,900,871, 8,927,277, 8,951,801, 9,213,999, 9,404,124, 9,499,797, 9,677,141, 9,714,433, and 9,938,585 and foreign counterparts thereof, including their divisions, continuations, extensions, substitutions, and those claiming priority therefrom or those claiming the same priorities therein.
This custom service is provided by Takara Bio Inc. and/or its affiliate(s) based on a patent license from iPS Academia Japan, Inc. No express or implied license is granted to the purchaser. "Product" means the customized differentiated cells manufactured and sold by Takara Bio Inc.
"Internal research purpose" means the use of this Product as a tool of internal research for the sole benefit of the purchaser or purchaser's contract research customer, (including screening of compounds, antibodies, proteins, peptides and others in developing pharmaceuticals (including diagnostic agents) for human and/or animal use), provided, however, that the following activities using this Product are strictly prohibited and expressly excluded from Internal research purposes;
With the exemption for academic and non-commercial clinical research done by non-profit institutions;
1) Administration of this Product to humans.
2) Use of this Product for the diagnostic testing, prevention, or treatment of human and/or animal diseases.
3) Use of this Product in studies involving administration to humans for cell therapy, regenerative medicine etc.
Purchaser may use this Product for its own Internal research purposes.
Purchaser shall not use the Products for its commercial purposes.
Notwithstanding the foregoing, the purchaser of this Product may provide third parties with contract research services by using this Product only for such third party's Internal research purposes.
センダイウイルスベクター（CytoTune-iPS 2.0）を用いて作製したiPS細胞 
L71 Reprogramming using Sendai technology
This service is performed by Takara Bio Inc. and/or its affiliate(s) based on a commercial license to certain intellectual property rights held by ID Pharma Co.,Ltd. The deliverables and their use are covered by one or more claims of patents owned by ID Pharma, including PCT/JP96/03068, PCT/JP96/03069, PCT/JP00/03195, PCT/JP2009/062911, PCT/JP2011/069588 and PCT/JP2014/75248 and their foreign counterparts. The purchase of this service conveys to the buyer the non-transferable right to use the deliverables for their intended use, strictly limited to purchaser's own internal research. No other express or implied license is granted to the purchaser. Purchaser cannot have any right to use the deliverables or its components in humans for any purposes including but not limited to diagnostics and/or therapeutics, or otherwise clinical trials. Purchase does not include any right to resell or transfer the deliverables to a third party regardless of whether or not compensation is received. Purchase does not include any right to provide Contract Manufacturing Service with the use of the deliverables to a third party, unless a license is negotiated with ID Pharma Co., Ltd. Purchasers wishing to use the deliverables for purposes other than internal research use should contact us.
C007 DE-cells
This product is manufactured and sold by Takara Bio Inc. and/or its affiliate(s) (“Takara”) under a license from ViaCyte Inc. (“ViaCyte”). This product is covered by one or more claims of patents owned by ViaCyte, including WO2005063971, WO2006017134, WO2006071911, WO2005116073 and WO2006016999, and their foreign counterparts.
The use of this product is strictly limited to purchaser's own internal research. Purchaser has no right to use this product or its components in humans for any purposes including but not limited to diagnostics, therapeutics, or clinical trials. Purchaser has no right to resell or transfer this product to a third party regardless of whether or not compensation is received. Purchasers wishing to use this product for purposes other than internal research use should contact Takara. No express or implied license is granted to the purchaser.
遺伝子・細胞プロセッシングセンター
